User profiles for P.M. Foreman
 | Paul ForemanOrlando Health, Orlando Regional Medical Center Verified email at orlandohealth.com Cited by 3021 |
[HTML][HTML] Oncolytic virotherapy for the treatment of malignant glioma
Malignant glioma is the most common primary brain tumor and carries a grim prognosis,
with a median survival of just over 14 months. Given the poor outcomes with standard-of-care …
with a median survival of just over 14 months. Given the poor outcomes with standard-of-care …
Preoperative embolization of spinal tumors: a systematic review and meta-analysis
Background Spinal tumors are referred for preoperative embolization to minimize intraoperative
blood loss and facilitate surgical resection. Objective To perform a systematic review …
blood loss and facilitate surgical resection. Objective To perform a systematic review …
[HTML][HTML] Blunt traumatic extracranial cerebrovascular injury and ischemic stroke
PM Foreman, MR Harrigan - Cerebrovascular Diseases Extra, 2017 - karger.com
Background: Ischemic stroke occurs in a significant subset of patients with blunt traumatic
cerebrovascular injury (TCVI). The patients are victims of motor vehicle crashes, assaults or …
cerebrovascular injury (TCVI). The patients are victims of motor vehicle crashes, assaults or …
Design of a phase I clinical trial to evaluate M032, a genetically engineered HSV-1 expressing IL-12, in patients with recurrent/progressive glioblastoma multiforme …
DM Patel, PM Foreman, LB Nabors… - Human Gene …, 2016 - liebertpub.com
M032 is a second-generation oncolytic herpes simplex virus (oHSV) that selectively
replicates in tumor cells. M032 kills tumor cells directly through oncolytic replication and then …
replicates in tumor cells. M032 kills tumor cells directly through oncolytic replication and then …
Use of platelet function testing before pipeline embolization device placement: a multicenter cohort study
Background and Purpose— Thromboembolic complications constitute a significant source
of morbidity after neurointerventional procedures. Flow diversion using the pipeline …
of morbidity after neurointerventional procedures. Flow diversion using the pipeline …
Pipeline embolization of posterior circulation aneurysms: a multicenter study of 131 aneurysms
OBJECTIVE Flow diversion for posterior circulation aneurysms performed using the Pipeline
embolization device (PED) constitutes an increasingly common off-label use for otherwise …
embolization device (PED) constitutes an increasingly common off-label use for otherwise …
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases
…, SR Marcrom, JB Fiveash, PM Foreman… - Neuro …, 2019 - academic.oup.com
… Paul M Foreman , Paul M Foreman … Roshan S Prabhu, Brandon E Turner, Anthony L
Asher, Samuel R Marcrom, John B Fiveash, Paul M Foreman, Robert H Press, Kirtesh R Patel, …
Asher, Samuel R Marcrom, John B Fiveash, Paul M Foreman, Robert H Press, Kirtesh R Patel, …
Postoperative radiosurgery for the treatment of metastatic brain tumor: evaluation of local failure and leptomeningeal disease
PM Foreman, BE Jackson, KP Singh, AK Romeo… - Journal of Clinical …, 2018 - Elsevier
In patients undergoing surgical resection of a metastatic brain tumor, whole brain radiation
therapy reduces the risk of recurrence and neurologic death. Focal radiation has the potential …
therapy reduces the risk of recurrence and neurologic death. Focal radiation has the potential …
Predictors of incomplete occlusion following Pipeline embolization of intracranial aneurysms: is it less effective in older patients?
…, CJ Griessenauer, PM Foreman… - American Journal …, 2017 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Flow diversion with the Pipeline Embolization Device (PED)
for the treatment of intracranial aneurysms is associated with a high rate of aneurysm …
for the treatment of intracranial aneurysms is associated with a high rate of aneurysm …
Pipeline embolization device for small intracranial aneurysms: evaluation of safety and efficacy in a multicenter cohort
BACKGROUND: To date, the use of the flow-diverting Pipeline Embolization Device (PED)
for small intracranial aneurysms (≤ 7 mm) has been reported only in single-center series. …
for small intracranial aneurysms (≤ 7 mm) has been reported only in single-center series. …
